WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2015125118) USPA2 PROTEIN CONSTRUCTS AND USES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2015/125118    International Application No.:    PCT/IB2015/051308
Publication Date: 27.08.2015 International Filing Date: 20.02.2015
IPC:
A61K 39/00 (2006.01), C07K 16/12 (2006.01), C07K 14/21 (2006.01)
Applicants: GLAXOSMITHKLINE BIOLOGICALS SA [BE/BE]; rue I'Institut 89 B-1330 Rixensart (BE)
Inventors: BLAIS, Normand; (CA).
CASTADO, Cindy; (BE).
CHOMEZ, Patrick; (BE).
DEWERCHIN, Marianne; (BE)
Priority Data:
61/943,909 24.02.2014 US
61/946,932 03.03.2014 US
61/946,937 03.03.2014 US
Title (EN) USPA2 PROTEIN CONSTRUCTS AND USES THEREOF
(FR) CONSTRUCTIONS DE PROTÉINE USPA2 ET LEURS UTILISATIONS
Abstract: front page image
(EN)The present invention relates to compositions comprising Moraxella catarrhalis (M. catarrhalis) Ubiquitous surface protein A2 (UspA2). More particularly, the present application relates to UspA2 protein constructs and immunogenic compositions, comprising the constructs, vaccines comprising such immunogenic compositions and therapeutic uses of the same. The invention further relates to compositions comprising UspA2 in combination with at least one antigen from Haemophilus influenzae, immunogenic compositions comprising the antigens, vaccines comprising such immunogenic compositions and therapeutic uses of the same.
(FR)La présente invention concerne des compositions comprenant une protéine de surface A2 Moraxella catarrhalis (M catarrhalis) (UspA2). En particulier, la présente invention concerne des constructions de protéine d'UspA2 et des compositions immunogènes comprenant lesdites constructions, des vaccins comprenant ces compositions immunogènes, et leurs utilisations thérapeutiques. L'invention concerne en outre des compositions comprenant l'UspA2 en combinaison avec au moins un antigène provenant de Haemophilus influenzae, des compositions immunogènes comprenant les antigènes, des vaccins comprenant de telles compositions immunogènes et leurs utilisations thérapeutiques.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)